Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108


The glycosaminoglycan-binding domain of decoy receptor 3 is essential for induction of monocyte adhesion.

Chang YC, Chan YH, Jackson DG, Hsieh SL.

J Immunol. 2006 Jan 1;176(1):173-80.


Decoy receptor 3 suppresses TLR2-mediated B cell activation by targeting NF-κB.

Huang ZM, Kang JK, Chen CY, Tseng TH, Chang CW, Chang YC, Tai SK, Hsieh SL, Leu CM.

J Immunol. 2012 Jun 15;188(12):5867-76. doi: 10.4049/jimmunol.1102516. Epub 2012 May 11.


Enhanced adhesion of monocytes via reverse signaling triggered by decoy receptor 3.

Hsu MJ, Lin WW, Tsao WC, Chang YC, Hsu TL, Chiu AW, Chio CC, Hsieh SL.

Exp Cell Res. 2004 Jan 15;292(2):241-51.


Immunomodulatory effect of decoy receptor 3 on the differentiation and function of bone marrow-derived dendritic cells in nonobese diabetic mice: from regulatory mechanism to clinical implication.

Wu SF, Liu TM, Lin YC, Sytwu HK, Juan HF, Chen ST, Shen KL, Hsi SC, Hsieh SL.

J Leukoc Biol. 2004 Feb;75(2):293-306. Epub 2003 Nov 21.


DcR3 induces cell proliferation through MAPK signaling in chondrocytes of osteoarthritis.

Hayashi S, Nishiyama T, Miura Y, Fujishiro T, Kanzaki N, Hashimoto S, Matsumoto T, Kurosaka M, Kuroda R.

Osteoarthritis Cartilage. 2011 Jul;19(7):903-10. doi: 10.1016/j.joca.2011.03.005. Epub 2011 Mar 21.


Decoy receptor 3 (DcR3) induces osteoclast formation from monocyte/macrophage lineage precursor cells.

Yang CR, Wang JH, Hsieh SL, Wang SM, Hsu TL, Lin WW.

Cell Death Differ. 2004 Jul;11 Suppl 1:S97-107.


Apoptosis of dendritic cells induced by decoy receptor 3 (DcR3).

You RI, Chang YC, Chen PM, Wang WS, Hsu TL, Yang CY, Lee CT, Hsieh SL.

Blood. 2008 Feb 1;111(3):1480-8. Epub 2007 Nov 15.


Modulation of T-cell responses to alloantigens by TR6/DcR3.

Zhang J, Salcedo TW, Wan X, Ullrich S, Hu B, Gregorio T, Feng P, Qi S, Chen H, Cho YH, Li Y, Moore PA, Wu J.

J Clin Invest. 2001 Jun;107(11):1459-68.


Tumor vaccine based on cell surface expression of DcR3/TR6.

Shi G, Mao J, Yu G, Zhang J, Wu J.

J Immunol. 2005 Apr 15;174(8):4727-35.


Decoy receptor 3 expressed in rheumatoid synovial fibroblasts protects the cells against Fas-induced apoptosis.

Hayashi S, Miura Y, Nishiyama T, Mitani M, Tateishi K, Sakai Y, Hashiramoto A, Kurosaka M, Shiozawa S, Doita M.

Arthritis Rheum. 2007 Apr;56(4):1067-75.


Identification of cell adhesive active sites in the N-terminal domain of thrombospondin-1.

Clezardin P, Lawler J, Amiral J, Quentin G, Delmas P.

Biochem J. 1997 Feb 1;321 ( Pt 3):819-27.


Quantification and detection of DcR3, a decoy receptor in TNFR family.

Chen J, Zhang L, Kim S.

J Immunol Methods. 2004 Feb 1;285(1):63-70.


Neutrophil cell surface receptors and their intracellular signal transduction pathways.

Futosi K, Fodor S, Mócsai A.

Int Immunopharmacol. 2013 Nov;17(3):638-50. doi: 10.1016/j.intimp.2013.06.034. Epub 2013 Aug 30. Review.


Decoy receptor 3 (DcR3) is proteolytically processed to a metabolic fragment having differential activities against Fas ligand and LIGHT.

Wroblewski VJ, Witcher DR, Becker GW, Davis KA, Dou S, Micanovic R, Newton CM, Noblitt TW, Richardson JM, Song HY, Hale JE.

Biochem Pharmacol. 2003 Feb 15;65(4):657-67.


Modulation of macrophage differentiation and activation by decoy receptor 3.

Chang YC, Hsu TL, Lin HH, Chio CC, Chiu AW, Chen NJ, Lin CH, Hsieh SL.

J Leukoc Biol. 2004 Mar;75(3):486-94. Epub 2003 Dec 4.


Sensitization of cells to TRAIL-induced apoptosis by decoy receptor 3.

Wu YY, Chang YC, Hsu TL, Hsieh SL, Lai MZ.

J Biol Chem. 2004 Oct 15;279(42):44211-8.

Supplemental Content

Support Center